Strategic Blueprint’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$469K Buy
6,632
+771
+13% +$57.7K 0.03% 423
2025
Q4
$463K Buy
5,861
+735
+14% +$58.2K 0.03% 416
2025
Q3
$422K Buy
5,126
+740
+17% +$58.2K 0.02% 514
2025
Q2
$353K Buy
4,386
+878
+25% +$67.8K 0.02% 521
2025
Q1
$282K Buy
3,508
+448
+15% +$37.3K 0.02% 554
2024
Q4
$251K Buy
3,060
+202
+7% +$16.8K 0.01% 573
2024
Q3
$236K Sell
2,858
-2,576
-47% -$192K 0.01% 580
2024
Q2
$381K Buy
5,434
+111
+2% +$7.92K 0.03% 438
2024
Q1
$394K Buy
5,323
+151
+3% +$10.5K 0.03% 430
2023
Q4
$342K Sell
5,172
-295
-5% -$18.5K 0.03% 422
2023
Q3
$344K Buy
5,467
+217
+4% +$13.5K 0.03% 385
2023
Q2
$297K Buy
5,250
+483
+10% +$26.8K 0.03% 427
2023
Q1
$276K Buy
4,767
+1,091
+30% +$73.6K 0.03% 434
2022
Q4
$266K Buy
+3,676
New +$263K 0.03% 422
2021
Q3
Sell
-761
Closed -$46K 940
2021
Q2
$46K Buy
+761
New +$48.2K 0.01% 642
2019
Q4
Sell
-210
Closed -$10K 291
2019
Q3
$10K Buy
+210
New +$10K 0.01% 296

Other funds holding MET

Strategic Blueprint's MET Position: Q1 2026 in Review

Strategic Blueprint increased its MetLife (MET) stake by 13% in Q1 2026, buying an estimated $57.7K and bringing the position to 6,632 shares worth $469K. The position accounts for 0.03% of the portfolio, ranked #423.

Strategic Blueprint first reported a position in MET in Q3 2019 and has held it in 16 quarters since. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Strategic Blueprint held 6,632 shares of MetLife worth $469K as of Q1 2026.
  • Strategic Blueprint bought 771 MetLife shares in Q1 2026, an estimated $57.7K.
  • MetLife made up 0.03% of Strategic Blueprint's portfolio in Q1 2026, its #423 holding.
  • Strategic Blueprint first reported a position in MetLife in Q3 2019 and has held it in 16 quarters since.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Strategic Blueprint's 13F filing for Q1 2026, filed 29 Apr 2026.